UC Berkeley loses CRISPR patent at EPO

25-05-2021

Muireann Bolger

UC Berkeley loses CRISPR patent at EPO

Sundry Photography / Shutterstock.com

The University of California Berkeley (UCB) has lost a CRISPR patent in Europe in the latest twist in the long-running IP saga over the gene-editing technology.


UC Berkeley, EPO, CRISPR, gene-editing, Broad Institute, DNA, patent, prior art, inventive step

LSIPR